You are using an outdated browser. Please upgrade your browser to improve your experience.
status/post MBCT

The Bronx Mindfulness-Based Cognitive Therapy (MBCT) for Migraine study is a randomized clinical trial designed to assess whether MBCT for Migraine reduces migraine-related disability compared to wait-list/treatment-as-usual

The Bronx Mindfulness-Based Cognitive Therapy (MBCT) for Migraine study is a randomized clinical trial designed to assess whether MBCT for Migraine reduces migraine-related disability compared to wait-list/treatment-as-usual

status/post MBCT

by Christopher Metts
status/post MBCT
status/post MBCT
status/post MBCT

What is it about?

The Bronx Mindfulness-Based Cognitive Therapy (MBCT) for Migraine study is a randomized clinical trial designed to assess whether MBCT for Migraine reduces migraine-related disability compared to wait-list/treatment-as-usual. Consented participants provide daily information regarding migraine symptoms and daily functioning for 30 days, and are then randomized to receive 8 weeks of either individual weekly 90-minute sessions of MBCT, or wait-list/treatment-as-usual. All participants then complete a final 30 days of daily information regarding migraine symptoms and daily functioning. The target audience is adults (18-65) with migraine who experience headache on 6-29 days per month.

status/post MBCT

App Details

Version
1.0
Rating
NA
Size
58Mb
Genre
Health & Fitness Medical
Last updated
April 12, 2017
Release date
April 12, 2017
More info

App Screenshots

status/post MBCT screenshot-0
status/post MBCT screenshot-1
status/post MBCT screenshot-2
status/post MBCT screenshot-3

App Store Description

The Bronx Mindfulness-Based Cognitive Therapy (MBCT) for Migraine study is a randomized clinical trial designed to assess whether MBCT for Migraine reduces migraine-related disability compared to wait-list/treatment-as-usual. Consented participants provide daily information regarding migraine symptoms and daily functioning for 30 days, and are then randomized to receive 8 weeks of either individual weekly 90-minute sessions of MBCT, or wait-list/treatment-as-usual. All participants then complete a final 30 days of daily information regarding migraine symptoms and daily functioning. The target audience is adults (18-65) with migraine who experience headache on 6-29 days per month.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to [email protected] and your information will be removed.